Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia

Torre, 2015, Global cancer statistics, 2012, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 Wood, 2012, Lung cancer screening, J Natl Compr Canc Netw, 10, 240, 10.6004/jnccn.2012.0022 Detterbeck, 2013, Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e78S, 10.1378/chest.12-2350 Wender, 2013, American Cancer Society lung cancer screening guidelines, CA Cancer J Clin, 63, 106, 10.3322/caac.21172 U.S. Centers for Medicare and Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed May 8, 2018. Lewin, 2016, Recommendations on screening for lung cancer, CMAJ, 188, 425, 10.1503/cmaj.151421 Oudkerk, 2017, European position statement on lung cancer screening, Lancet Oncol, 18, e754, 10.1016/S1470-2045(17)30861-6 Black, 2014, Cost-effectiveness of CT screening in the National Lung Screening Trial, N Engl J Med, 371, 1793, 10.1056/NEJMoa1312547 Raymakers, 2016, Cost-effectiveness analyses of lung cancer screening strategies using low-dose computed tomography: a systematic review, Appl Health Econ Health Policy, 14, 409, 10.1007/s40258-016-0226-5 Puggina, 2016, Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review, Eur J Public Health, 26, 168, 10.1093/eurpub/ckv158 The Standing Committee on Screening, Position Statement: Lung Cancer Screening using Low-Dose Computed Tomography. Australian Government Department of Health, 2015. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/lung-cancer-screening. Accessed May 8, 2018. Manser, 2005, Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting, Lung Cancer, 48, 171, 10.1016/j.lungcan.2004.11.001 Fenwick, 2006, Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation, BMC Health Serv Res, 6, 52, 10.1186/1472-6963-6-52 Aberle, 2011, The National Lung Screening Trial: overview and study design, Radiology, 258, 243, 10.1148/radiol.10091808 Oken, 2011, Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial, JAMA, 306, 1865, 10.1001/jama.2011.1591 Cancer Institute NSW, Cancer survival in New South Wales 1995-2009, 2016. https://www.cancerinstitute.org.au/how-we-help/reports-and-publications/cancer-survival-in-nsw-1995-2009. Accessed June 27, 2016. 2001 Australian Bureau of Statistics. Life Tables, States, Territories and Australia 2013-2015, 2016. http://www.abs.gov.au/ausstats/[email protected]/mf/3302.0.55.001. Accessed January 31, 2017. Thun, 2013, 50-year trends in smoking-related mortality in the United States, N Engl J Med, 368, 351, 10.1056/NEJMsa1211127 Berrington de Gonzalez, 2008, Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk, J Med Screen, 15, 153, 10.1258/jms.2008.008052 Australian Bureau of Statistics. Consumer Price Index, Australia, 2016. Available at: http://www.abs.gov.au/Ausstats/[email protected]/mf/6401.0. Accessed November 7, 2016. Kang, 2012, Cost analysis of lung cancer management in South Western Sydney, J Med Imaging Radiat Oncol, 56, 235, 10.1111/j.1754-9485.2012.02354.x Medical Services Advisory Committee. Technical Guidelines for preparing assessment reports for the Medical Services Advisory Committee - Service Type: Investigative (Version 3.0). Australian Government Department of Health, 2016. http://www.msac.gov.au/internet/msac/publishing.nsf/Content/applicants. Accessed January 23, 2017. Fryback, 2007, US norms for six generic health-related quality-of-life indexes from the National Health Measurement study, Med Care, 45, 1162, 10.1097/MLR.0b013e31814848f1 Kucharczyk, 2011, Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography, Can Assoc Radiol J, 62, 141, 10.1016/j.carj.2010.02.008 Kinsinger, 2017, Implementation of lung cancer screening in the Veterans Health Administration, JAMA Intern Med, 177, 399, 10.1001/jamainternmed.2016.9022 Marshall, 2013, Queensland Lung Cancer Screening Study: rationale, design and methods, Intern Med J, 43, 174, 10.1111/j.1445-5994.2012.02789.x Marshall, 2015, Lung cancer screening feasibility in Australia, Eur Respir J, 45, 1734, 10.1183/09031936.00208714 Pinsky, 2015, Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment, Ann Intern Med, 162, 485, 10.7326/M14-2086 Heuvelmans, 2018, Management of baseline and new sub-solid nodules in CT lung cancer screening, Expert Rev Respir Med, 12, 1, 10.1080/17476348.2018.1398087 Ten Haaf, 2017, Performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting: a microsimulation modeling analysis in Ontario, Canada, PLoS Med, 14, e1002225, 10.1371/journal.pmed.1002225 McMahon, 2011, Cost-effectiveness of computed tomography screening for lung cancer in the United States, J Thorac Oncol, 6, 1841, 10.1097/JTO.0b013e31822e59b3 Treskova, 2017, Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting, BMC Med, 15, 162, 10.1186/s12916-017-0924-3 Lew JB, Simms K, Smith M, et al. National Cervical Screening Program renewal: effectiveness modelling and economic evaluation in the Australian setting. Report to the Medical Services Advisory Committee. Commonwealth of Australia, Canberra, 2014. Villanti, 2013, A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions, PLoS One, 8, e71379, 10.1371/journal.pone.0071379 Nair, 2016, Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial, Br J Radiol, 89, 20160301, 10.1259/bjr.20160301 Ritchie, 2016, Computer vision tool and technician as first reader of lung cancer screening CT scans, J Thorac Oncol, 11, 709, 10.1016/j.jtho.2016.01.021 Heuvelmans, 2015, Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening, J Thorac Imaging, 30, 101, 10.1097/RTI.0000000000000135 Infante, 2017, Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials, Eur J Cancer Prev, 26, 324, 10.1097/CEJ.0000000000000264 Mahadevia, 2003, Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis, JAMA, 289, 313, 10.1001/jama.289.3.313 Tammemaegi, 2014, Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts, PLoS Med, 11 Marcus, 2015, LLPi. Liverpool Lung Project risk prediction model for lung cancer incidence, Cancer Prev Res (Phila), 8, 570, 10.1158/1940-6207.CAPR-14-0438 McWilliams, 2013, Probability of cancer in pulmonary nodules detected on first screening CT, N Engl J Med, 369, 910, 10.1056/NEJMoa1214726 Cressman, 2017, The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency, J Thorac Oncol, 12, 1210, 10.1016/j.jtho.2017.04.021 Field, 2016, The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer, Health Technol Assess, 20, 1, 10.3310/hta20400 Lin, 2010, Radiation risk from medical imaging, Mayo Clin Proc, 85, 1142, 10.4065/mcp.2010.0260 van den Bergh, 2010, Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON), Br J Cancer, 102, 27, 10.1038/sj.bjc.6605459 Earle, 2000, Systematic overview of cost-utility assessments in oncology, J Clin Oncol, 18, 3302, 10.1200/JCO.2000.18.18.3302 Karikios, 2014, Rising cost of anticancer drugs in Australia, Intern Med J, 44, 458, 10.1111/imj.12399 Australian Institute of Health and Welfare, National Bowel Cancer Screening Program: monitoring report 2017. Cancer series no. 103. Cat. no. CAN 103. AIHW Canberra, 2017. Australian Institute of Health and Welfare, Health system expenditure on cancer and other neoplasms in Australia, 2008-2009. Cancer series no. 81. Cat. no. 78. AIHW Canberra, 2009.